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Abstract 
In a new study, Schwartz and colleagues have investigated the best way to estimate glomerular filtration rate 
(GFR) in children. Having already improved GFR estimation with the use of creatinine-based equations, the 
investigators now propose a more precise method for cystatin C measurement. The precision of a GFR equation 
will strongly depend on the analytical precision of the biological variables included. 
 
In children with chronic kidney disease, measuring glomerular filtration rate (GFR) is the best indicator of global 
kidney function.
1
 Because measuring GFR remains relatively cumbersome and costly, however, estimating GFR 
using renal biomarkers remains relevant for daily practice. In 1976, Schwartz et al. proposed an equation where 
the parameter height/serum creatinine was multiplied by a constant (k) to estimate creatinine clearance.
2
 This 
original Schwartz equation has been popular for several decades, but was based on the colourimetric Jaffe 
creatinine measurement method. Measuring serum creatinine levels by a precise and reproducible method is 
especially important in children because their mean serum concentrations are lower than those in adults and are 
thus more prone to interferences, for example from proteins present in the serum. Therefore, it is now 
recommended that serum creatinine levels should be measured by enzymatic methods in children.
3
 
"By optimizing the measurements of cystatin C, they improve the estimation of GFR in children..." 
Changing from the Jaffe method to enzymatic methods had a large impact on the k value in the original Schwartz 
equation.
3,4
 In 2009, Schwartz et al. recalculated the k value of the estimating equation to be used with the 
enzymatic method and plasma iohexol clearance measurement as a reference method to assess GFR.
4
 The fact 
that most of the enzymatic methods available in 2012 are isotope dilution mass spectrometry (IDMS)-traceable 
means that an identical equation can be used in all laboratories, which is very important from a practical point of 
view
5
 However, a limitation of the 2009 study was that the equation was not validated in an independent 
validation cohort. In the same publication, the researchers studied the performance of the new renal biomarker 
cystatin C. In contrast to prior studies, Schwartz and colleagues demonstrated that cystatin C was less predictive 
of measured GFR than was height/serum creatinine, which resulted in a less powerful cystatin C exponent in the 
final equation compared with height/serum creatinine. This final equation included other variables such as blood 
urea nitrogen (BUN), height and sex.
4
 One major issue was the turbidimetric method used to measure cystatin C, 
which has later been demonstrated as relatively imprecise. 
In 2012, Schwartz and colleagues studied children included in the Chronic Kidney Disease in Children (CKiD) 
study in order to determine the best way to estimate GFR.
6 
Only individuals aged between 1 year and 16 years 
with an initial estimated GFR of 30-60 ml/min/1.73 m
2
 (by the original Schwartz equation) were included. GFR 
results were available for 965 patients, of whom two-thirds were randomly chosen for the training set and one-
third for the validation sample. Both samples were similar in terms of age, height, sex and median measured 




 In contrast to the 2009 study, cystatin C was measured by the particle-enhanced 
nephelometric immunoassay (PENIA) method. Measuring cystatin C by both turbidimetric and nephelometric 
assays in 646 individuals, Schwartz et al. found a better correlation between cystatin C and measured GFR with 
the PENIA method than with the turbidimetric assay (0.87 versus 0.74, respectively). As a result of the improved 
correlation, cystatin C had the same predictive power as height/serum creatinine to estimate GFR. Moreover, the 
performance of the univariate cystatin C equation was slightly better than the updated 2012 Schwartz creatinine 
equation. Indeed, in the validation dataset, the accuracy of the univariate height/serum creatinine equation and 
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univariate cystatin C equation— defined as the percentage of estimated GFR within 30% of measured GFR—
was 80% and 83%, respectively. Accuracy of bivariate equations that included both cystatin C and creatinine 
(89%) was better than that of equations combining BUN and cystatin C or BUN and serum creatinine (82% and 
84%, respectively). The best accuracy of 91% was observed in the equations that included cystatin C, 
height/serum creatinine, height, sex and BUN. Such a high accuracy is impressive and has rarely been achieved 
in either paediatric or adult studies of GFR estimation. 
There are several explanations for such a high accuracy and precision. The precision of a GFR equation will 
strongly depend on the analytical precision of the biological variables included (enzymatic, IDMS-traceable 
method for creatinine and PENIA method for cystatin C).
5
 The precision of the reference method used to 
measure GFR is also of high importance. The plasma iohexol clearance used by Schwartz et al. is precise and 
reproducible in children.
7
 Even if plasma clearance may be considered less physiological than urinary clearance, 
there is little doubt regarding its precision and biological variability, especially in children in whom urological 
disorders and malformations are frequent and toilet training is not always fully accomplished. The last 
explanation for the high accuracy observed in this study is also one of its limitations. Indeed, even if the new 
equations have been validated in an internal validation cohort, it is obvious that equations always perform best in 
cohorts they were derived from. In other words, these new equations still need to be validated externally. Also, 
only children with CKD were studied in the CKiD cohort. Therefore, the performance in individuals with higher 
GFR levels should also be studied. There is actually a risk that equations (notably creatinine-based equations) 
underestimate measured GFR.
8,9
 Accuracy of the various equations, especially the cystatin C and combined 
equations, should also be studied in children with abnormal muscular mass (such as spina bifida) because even 
the updated Schwartz equation would probably overestimate measured GFR in these children. Two other 
limitations of this study should be mentioned. First, the investigators included the variable BUN in their final 
equation. It is, however, not clear if the same type of equation (that includes height and sex) without BUN would 
have a worse performance. Indeed, including an additional biological variable could add potential imprecision 
owing to analytical and biological variation of this variable. Also, as stated by the authors, BUN measurement is 
not standardized. 
Second, recent data, notably in adults, have indicated that standardization of cystatin C measurement by PENIA 
methods should be done with the new reference material (ERM-DA471/IFCC).
10
 It is not clear if Schwartz and 
colleagues used this standard. Differences in calibration (as a result of lack of standardization) would change the 
cystatin C concentrations and therefore also change the values of the exponents applied to cystatin C. 
Whatever the limitations of this study maybe, Schwartz and colleagues have once again added another important 
brick in the wall. By optimizing the measurements of cystatin C, they improve the estimation of GFR in children, 
which is important in daily practice. We must keep in mind, however, a fact also underlined by the authors, that 
measuring GFR using a reference method remains essential in specific situations. 
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